From a subspecialty department within a university medical center, to seamless integration of our AP LIS with enterprise-wide regional systems, the flexibility of NovoPath’s scalable LIS will provide a robust, intuitive tailored system.
PRINCETON, NJ (PRWEB) August 24, 2012
NovoPath, Inc., a leader in Anatomic Pathology Best-of-Breed Software Solutions, announces additions to their list of partnerships.
The University of Missouri School of Medicine, established more than 160 years ago, was the first public medical school west of the Mississippi River. Their newly formed Department of Dermatopathology is dedicated to providing high quality care for their patients, and exceptional educational experiences for their residents and students.
In addition, two highly respected regional medical centers required a Best-of-Breed AP LIS to flawlessly interface with their enterprise-wide information systems. Southeast Hospital in Cape Girardeau, part of Missouri’s SoutheastHEALTH medical complex, is a leading provider of health services dedicated to continuous improvement of the region's health status in a collaborative cost-effective manner.
Not-for-profit Missouri Delta Medical Center is a proud provider of comprehensive medical care to the residents of Southeast Missouri. Founded in Sikeston in 1948, Missouri Delta Medical Center is continually committed to providing high quality, accessible healthcare services.
These three Missouri-based healthcare leaders are the latest hospitals to join the growing group of NovoPath clients. Wally Soufi, NovoPath CEO, observed, "We look forward to working with our new partners in Missouri to customize our AP LIS to match each lab's unique requirements. From a subspecialty department within a university medical center, to seamless integration of our AP LIS with enterprise-wide regional systems, the flexibility of NovoPath’s scalable LIS will provide a robust, intuitive system tailored to enhance the operation and profitability of each institution’s pathology lab.”
About NovoPath, Inc.:
NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at http://www.NovoPath.com.